Increased ventilatory response to exercise in symptomatic and asymptomatic LMNA mutation carriers: a follow-up study

Laura Ollila1, Tiina Heliö1, Anssi Sovijärvi2

  • 1Heart and Lung Centre, Helsinki University Central Hospital, Helsinki, Finland.

Insights

LMNA mutations can cause heart disease. Asymptomatic carriers show increased ventilatory response during exercise, suggesting a preclinical sign of lamin A/C (LMNA) cardiomyopathy.

Area of Science:

  • Cardiology
  • Genetics
  • Pulmonary Medicine

Background:

  • Mutations in the LMNA gene are a significant cause of cardiomyopathy, leading to arrhythmias, heart failure, and potentially heart transplantation.
  • Screening of family members identifies an increasing number of asymptomatic LMNA mutation carriers.
  • Cardiolaminopathy, caused by LMNA mutations, presents a spectrum of clinical manifestations.

Purpose of the Study:

  • To investigate disease progression in asymptomatic LMNA mutation carriers.
  • To compare disease progression in symptomatic cardiolaminopathy patients.
  • To utilize serial spiroergometric testing in a prospective follow-up study.

Main Methods:

  • 26 LMNA mutation carriers underwent annual spiroergometry, clinical assessment, lab tests, and echocardiography for up to 5 years.
  • 23 control subjects had a single clinical assessment and spiroergometry.
  • Mutation carriers were divided into asymptomatic (12) and symptomatic (14) groups.

Main Results:

  • Symptomatic carriers exhibited a higher ventilatory equivalent for CO2 (V˙E/V˙CO2 slope) and lower end-tidal CO2 (FetCO2) compared to controls.
  • Asymptomatic carriers also demonstrated an increased ventilatory response to exercise over the follow-up period.
  • This increased response was evidenced by a rising V˙E/V˙CO2 slope and decreasing FetCO2.

Conclusions:

  • An elevated ventilatory response during exercise may indicate a preclinical stage of dilated cardiomyopathy (DCM) in LMNA mutation carriers.
  • Spiroergometry can detect early functional changes in individuals with LMNA mutations.
  • This finding aids in identifying individuals at risk for developing symptomatic cardiolaminopathy.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
602
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
373
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.8K
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
3.5K
Hyperpnea and Hyperventilation01:25

Hyperpnea and Hyperventilation

Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
3.5K
Respiratory Volumes and Capacities01:22

Respiratory Volumes and Capacities

The respiratory system is responsible for the intake of oxygen and the expulsion of carbon dioxide from the body. Respiratory volumes describe the volume of air in the lungs at different phases of the respiratory cycle. Tidal volume is the air breathed in and out during normal, quiet breathing. Inspiratory reserve volume is the air that can be forcefully inspired beyond the tidal volume. In contrast, expiratory reserve volume refers to the air that can be expelled from the lungs after a normal...
6.4K